Total Funding
52
59
Total FundingSeries B raised
Growth Score
-1 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
37307
Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.
- Ricardo Dolmetsch: President
- Ricardo Dolmetsch: Founder
About the Company
Tempero Bio is a clinical-stage biopharmaceutical company developing treatments for substance use disorders and related conditions. It is part of the Aditum Bio portfolio and conducts research supported by external funding, including grants. The company focuses on addressing unmet medical needs through pharmaceutical development.
